Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
PMID 3085206
Fischer TW, Elsner P
According to a study presented at the 2025 Society of Hematologic Oncology (SOHO) meeting, patients with PV who received GLP-1 therapy experienced : - *Reduced All-Cause Mortality*: Lower odds of death from any cause - *Lower Rates of Myelofibrosis Progression*: Decreased risk of progression to myelofibrosis, a condition where scar tissue builds up in the bone marrow - *Decreased Venous Thromboembolism (VTE)*: Fewer blood clots - *Fewer Hospitalizations*: Reduced need for hospitalization - *Reduced Risk of Acute Kidney Injury and Ischemic Stroke*: Lower risk of kidney damage and stroke
A 2024 study in The Lancet found the US obesity rate has at least doubled in adults and older adolescents since 1990
US$ 22.57
US$ 24.67
US$ 22.82
